Substituted nicotinimide inhibitors of BTK for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12162873
APP PUB NO 20240101545A1
SERIAL NO

18496692

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula I, as shown below and defined herein:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GUANGZHOU INNOCARE PHARMA TECH CO LTDSINO-SINGAPORE GUANGZHOU KNOWLEDGE CITY GUANGZHOU GUANGDONG 510130

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Xiangyang Beijing, CN 52 629
Gao, Yingxiang Beijing, CN 14 13
Liu, Chong Beijing, CN 102 454
Ni, Haihong Beijing, CN 16 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 10, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 10, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00